Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) just unveiled an update.
Wai Chun Bio-Technology Limited has scheduled a board meeting in Hong Kong on 27 February 2026 to review and approve the unaudited interim results for the six months ended 31 December 2025. The meeting will also authorize the publication of these interim figures, providing investors and other stakeholders with an updated view of the group’s financial performance and governance activities.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Limited is a Cayman Islands-incorporated company listed on the Stock Exchange of Hong Kong, operating in the biotechnology sector. The group conducts its business through the company and its subsidiaries, with governance led by Chairman and Chief Executive Officer Lam Ka Chun alongside three independent non-executive directors.
Average Trading Volume: 157,924
Technical Sentiment Signal: Buy
Current Market Cap: HK$46.4M
For an in-depth examination of 0660 stock, go to TipRanks’ Overview page.